Markku Savolainen

Prof. Markku Savolainen

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2019 in Science Advances
Verified
Journal Article
Open access
AAAlexessander Couto Alves
Alexessander Couto Alves
NSN. Maneka G. De Silva
N. Maneka G. De Silva
VKVille Karhunen
Ville Karhunen
USUlla Sovio
Ulla Sovio
SDShikta Das
Shikta Das
ECEarly Growth Genetics (EGG) Consortium
Early Growth Genetics (EGG) Consortium
Longitudinal data find a new variant controlling BMI in infancy and reveal genetic differences between infant and adult BMI.

4 July 2018 in Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
ATA.‐M. Teeriniemi
A.‐M. Teeriniemi
TSTuire Salonurmi
Tuire Salonurmi
TJT. Jokelainen
T. Jokelainen
HVH. Vähänikkilä
H. Vähänikkilä
TAT. Alahäivälä
T. Alahäivälä
MSMarkku Savolainen
Markku Savolainen
Background: Weight loss can prevent and treat obesity‐related diseases. However, lost weight is usually regained, returning to the initial or even higher levels in the long term. New counselling methods for maintaining lifestyle changes are urgently needed.Objectives: An information and communication technology‐based health behaviour change support system (HBCSS) that utilizes persuasive design and methods of cognitive behavioural therapy (CBT) was developed with the aim of helping individuals to maintain body weight. The purpose of this study was to assess whether CBT‐based group counselling combined with HBCSS or HBCSS alone helps to maintain improved lifestyle changes needed for weight loss compared to self‐help guidance or usual care.Methods: A randomized lifestyle intervention for overweight or obese persons (BMI 27–35 kg m−2 and age 20–60 years), recruited from the population registry in the city of Oulu, Finland, was conducted. This study comprised six randomly assigned study arms: CBT‐based group counselling (eight sessions led by a nutritionist), self‐help guidance‐based group counselling (SHG; two sessions led by a nurse) and control, each with or without HCBSS, for 52 weeks. Subjects visited the study centre for anthropometric measurements, blood sample collection and to complete questionnaires at baseline, 12 and 24 months. The main outcome was weight change from baseline to 12 months and from baseline to 24 months.Results: Of the 1065 volunteers screened for the study, 532 subjects (51% men) met the inclusion criteria and were enrolled. The retention rate was 80% at 12 months and 70% at 24 months. CBT‐based counselling with HBCSS produced the largest weight reduction without any significant weight gain during follow‐up. The mean weight change in this arm was 4.1% [95% confidence interval (CI), −5.4 to −2.8, P < 0.001) at 12 months and 3.4% (95% CI, −4.8 to −2.0, P < 0.001) at 24 months. HBCSS even without any group counselling reduced the mean weight by 1.6% (95% CI, −2.9 to −0.3, P = 0.015) at 24 months.Conclusion: The combination of CBT‐based group counselling and HBCSS‐based weight management is feasible for overweight or obese individuals. Moreover, HBCSS alone could be disseminated to the population at large as an effective means of treating obesity.

3 May 2007 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
AVAki Vehtari
Aki Vehtari
VMVille-Petteri Mäkinen
Ville-Petteri Mäkinen
PSPasi Soininen
Pasi Soininen
PIPetri Ingman
Petri Ingman
SMSanna M Mäkelä
Sanna M Mäkelä
MAMika Ala-Korpela
Mika Ala-Korpela
A key challenge in metabonomics is to uncover quantitative associations between multidimensional spectroscopic data and biochemical measures used for disease risk assessment and diagnostics. Here we focus on clinically relevant estimation of lipoprotein lipids by 1H NMR spectroscopy of serum.

31 December 1991 in Life Sciences
Verified
Journal Article
Closed access
KKKari Kervinen
Kari Kervinen
MSMarkku Savolainen
Markku Savolainen
YKY Antero Kesäniemi
Y Antero Kesäniemi

Verified
Journal Article
Open access
PDF file
JRJustiina Ronkainen
Justiina Ronkainen
EMEleonora Mondini
Eleonora Mondini
FCFrancesca Cinti
Francesca Cinti
SCSaverio Cinti
Saverio Cinti
SSSylvain Sebért
Sylvain Sebért
TSTuire Salonurmi
Tuire Salonurmi
Genetic variants in the fat mass- and obesity-associated gene Fto are linked to the onset of obesity in humans. The causal role of the FTO protein in obesity is supported by evidence obtained from transgenic mice; however, the underlying molecular pathways pertaining to the role of FTO in obesity have yet to be established. In this study, we investigate the Fto gene in mouse brown adipose tissue and in the browning process of white adipose tissue. We analyze distinct structural and molecular factors in brown and white fat depots of Fto-deficient mice under normal and obesogenic conditions. We report significant alterations in the morphology of adipose tissue depots and the expression of mRNA and microRNA related to brown adipogenesis and metabolism in Fto-deficient mice. Furthermore, we show that high-fat feeding does not attenuate the browning process of Fto-deficient white adipose tissue as observed in wild-type tissue, suggesting a triggering effect of the FTO pathways by the dietary environment.

28 April 2008 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
ANAntti E. Nissinen
Antti E. Nissinen
SMSanna M. Mäkelä
Sanna M. Mäkelä
JVJussi T. Vuoristo
Jussi T. Vuoristo
MLMarja K. Liisanantti
Marja K. Liisanantti
MHMinna L. Hannuksela
Minna L. Hannuksela
MSMarkku Savolainen
Markku Savolainen